BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018

Jun 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-06-22

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-22	Common Stock	M	6949	$14.39	Acquired	90225	Direct
2018-06-22	Common Stock	S	6621	$99.00	Disposed	83604	Direct
2018-06-22	Common Stock	S	328	$99.01	Disposed	83276	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-22	Stock Option (Right to buy Common Stock)	$14.39	M	6949	Disposed	2019-05-11	Common Stock (6949)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	77055	Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on March 6, 2018.

F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.